𝔖 Bobbio Scriptorium
✦   LIBER   ✦

PL.02.01 Novel therapeutic targets for neuroprotection and disease modification in Parkinson's disease

✍ Scribed by Björklund, A.

Book ID
122375519
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
54 KB
Volume
23
Category
Article
ISSN
0924-977X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Parkinson's Disease Volume 1052 || C. El
Parkinson's Disease Volume 1052 || C. Elegans Genetic Strategies to Identify Novel Parkinson's Disease-associated Therapeutic Targets and Leads
✍ Nass, Richard 📂 Article 📅 2008 🏛 Elsevier 🌐 English ⚖ 27 KB

Parkinson’s disease is the second most prevalent neurodegenerative disease and is characterized by the irreversible loss of dopamine neurons. Despite its high prevalence in society and many decades of research, the origin of the pathogenesis and the molecular determinants involved in the disorder ha

Neuroprotective therapy in Parkinson's d
Neuroprotective therapy in Parkinson's disease and motor complications: A search for a pathogenesis-targeted, disease-modifying strategy
✍ C. Warren Olanow; Joseph Jankovic 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 1 views

The introduction of levodopa in the late 1960s represented a landmark in the therapy of Parkinson's disease (PD). However, motor complications of chronic levodopa therapy have emerged as a major limitation of this otherwise effective therapy. Advancing medical and surgical treatment of these complic